患者监护系统行业研究报告
2009年04月02日 来源:佐思
摘要
至2012年,美国对患者监护系统的需求以每年5.9%的比例增长,附属医用耗材将是增长最快的部分,例如受血糖试纸的影响。医疗仪器的增长焦点在利用网络与电话的远程监护上和家用医疗器械上。
这个研究分析了患者监护系统产业,它显示出1997,2002和2007年的纵向需求数据,预测了2012年和2017年的监护系统产品需求类型(例如:多参数、心脏、呼吸、血压、神经系统、脉搏);附属医用耗材(例如:血糖试纸、电极、导管、刺络针)和市场(例如、家庭医疗保健、医院、门诊实施及医师办公室)
这个研究也考虑到市场环境因素,产业结构细则、及对27个主要公司的市场份额及概况进行了评估。
Abstract
US demand for patient monitoring systesm will grow 5.9 percent annually through 2012. Accessories will be the fastest growing segment, driven by blood glucose testing strips. Growth in the equipment sector will be based on strength in remote monitors that transmit data via the Internet or telephone, and in home use devices.
This study analyzes the $9 billion US patient monitoring system industry. It presents historical demand data for the years 1997, 2002 and 2007, and forecasts for 2012 and 2017 by monitor type (e.g., multi-parameter, cardiac, respiratory, blood, temperature, neurological, fetal and neonatal, pulse); accessory type (e.g., blood glucose test strips, electrodes, lancets, catheters); and market (e.g., home health care, hospitals, outpatient facilities, physicians’ offices).
The study also considers market environment factors, details industry structure, evaluates company market share and profiles 27 major players, including Philips Healthcare, Johnson & Johnson, GE Healthcare, Roche, Medtronic, Abbott Laboratories, Bayer, Covidien, Becton Dickenson, and Welch Allyn.
目录及图表
TABLE OF CONTENTS
SECTION PAGE
INTRODUCTION x